Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/09/2008US20080248036 Treatment with anti-vegf antibodies
10/09/2008US20080248035 Pyrrole derivatives, dyslipidemic agents (cholesteryl ester transfer protein inhibitors), antiobesity agents (serontonin receptor inhibitors), antihyperglycemic agents (insulin sensitizing agents/PPAR agonists), anti-inflammatory agents
10/09/2008US20080248033 VEGF-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors
10/09/2008US20080248032 Using 2-acetyl-4-tetrahydroxybutylimidazole (THI) as therapeutic in treatment and prevention of heart and stroke injury
10/09/2008US20080248024 Using oligonucleotides specific to zinc finger protein 91 (ZFP91) as therapeutic inhibitors in treatment of cell proliferative, inflammatory and gastrointestinal disorders; RNA interference
10/09/2008US20080248022 Using inflammatory marker concentration as diagnostic/therapeutic indicator for administering vaccine agent for treatment and/or prevention of neurodegenerative disorders
10/09/2008US20080248020 Variant lyase for use in treatment and prevention of cell proliferative disorders
10/09/2008US20080248017 Multicompartment drug delivery system for use in treatment of menopausal symptoms and benign ovarian secretory disorder; contraceptive
10/09/2008US20080248015 Administering vitamin A, vitamin D, vitamin C, vitamin E, folic acid, vitamin B1, vitamin B2, vitamin B6, vitamin B12, niacin, calcium, iron, magnesium, zinc, copper, and omega-3 fatty acids; blister packs
10/09/2008US20080248013 Emulsifying in aqueous liquid containing water-soluble octenylsuccinate starch and dextrin, and glycerin; improved stability and bioavailability; foods; cosmetics
10/09/2008US20080248012 Modulator of adenosine triphosphate release from red blood cells; treating and preventing ischemic reperfusion injuries, cardiovascular and vasodilatory diseases
10/09/2008US20080248008 Transferase inhibitory mimetic for use in treatment and prevention of immunosuppressive, cell proliferative and autoimmune disorders
10/09/2008US20080248007 Nucleotide sequences coding protein associated with immune response for use in identifying modulators for prevention and treatment of immunodeficiency, autoimmue and inflammatory disorders
10/09/2008US20080248001 Methods and systems for treating cell proliferation disorders
10/09/2008US20080247996 Methods of treating neoplasia with combination target cell-specific adenovirus, chemotherapy and radiation
10/09/2008US20080247995 Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide
10/09/2008US20080247994 DNA vaccine
10/09/2008US20080247992 N-Carboxyalkyl-1-cyclohexyl-2-substituted phenylbenzimidazole-5-carboxamides (2-[(1-cyclohexyl-2-{2-fluoro-4-[3-(aminocarbonyl)-6-(4-chlorophenyl)benzyloxy]-phenyl}-1H-benzimidazole-5-carbonyl)-amino]-3-(5-hydroxy-1H-indol-3-yl)-propionic acid); Flavivirus family infections such as hepatitus C
10/09/2008US20080247988 Methods of making and using surfactant polymers
10/09/2008US20080247987 devices, and methods for the production, use and administration of the composition having a non-thermoreversible block copolymer composition.
10/09/2008US20080247986 Hyaluronidase Inhibitor Containing Poly-Gamma-Glutamic Acid as an Effective Component
10/09/2008US20080247985 Composition base containing solubilized allantoin and urea for topical preparations
10/09/2008US20080247984 DOPA functionalized, branched, polyalkylene oxide materials that are useful as adhesives, is a linker or is a linking group selected from amide, ester, urea, carbonate or urethane linking groups;
10/09/2008US20080247979 Use of a Hydrophobic Zeolite, that Contains and Gives a Slow Release of an Active Element, for Treatment of Skin
10/09/2008US20080247965 Metering valve and pressurized solution aerosol comprising bronchodilator, hydrofluorocarbon propellant, and cosolvent within container having inorganic coating
10/09/2008US20080247964 Substituted azaspiro derivatives
10/09/2008US20080247963 Quinuclidine Compounds Having Quaternary Ammonium Group, Its Preparation Method and Use as Blocking Agents of Acetylcholine
10/09/2008US20080247962 Pharmaceutical Compositions Comprising Higher Primary Aliphatic Alcohols and Hmg Coa Reductase Inhibitor and Process of Preparation Thereof
10/09/2008US20080247961 Nasally administrable compositions of zolpidem and methods of use
10/09/2008US20080247959 Form of administration secured against misuse
10/09/2008US20080247956 Identification of novel factors that block programmed cell death or apoptosis by targeting jnk
10/09/2008US20080247955 Detecting secreted phosphoprotein-1 and/or biomarkers; autoimmune diseases; antibodies; RNA interference
10/09/2008US20080247954 Especially oxazole, thiazole and imidazole compounds 2-substituted with phenyl -cycloalkyl or -bicycloalkyl groups; drug screening
10/09/2008US20080247953 Drug screening assays; SH2 docking domains; signal sequences; immunology; cyclophilins
10/09/2008US20080247950 Proteases of human kallikrein 2 (hK2); tissue imaging
10/09/2008DE102007016367A1 Polymorph von Clarithromycin (Form V) Polymorph of clarithromycin (Form V)
10/09/2008DE102007016283A1 Deoxy-D-glucose for producing drug for therapy of arteriosclerosis and arteriothrombosis, particularly for plaque structure in vessel, for preventing or treating restenosis, and for use with compound for continuous release
10/09/2008CA2800324A1 Zilpaterol and salts thereof for use in increasing the rate of weight gain, improved feed efficiency and/or increasing carcass leanness in a bovine
10/09/2008CA2718130A1 Surfactant lipids, compositions thereof, and uses thereof
10/09/2008CA2702305A1 Cancer cell targeting using nanoparticles
10/09/2008CA2701638A1 Pharmaceutical calcimimetics
10/09/2008CA2693254A1 Methods of treating metabolic syndrome using dopamine receptor agonists
10/09/2008CA2685965A1 Bioabsorbable elastomeric polymer networks, cross-linkers and methods of use
10/09/2008CA2683217A1 Compositions for nasal delivery
10/09/2008CA2682736A1 Combined use of dipeptidyl peptidase 4 inhibitor and sweetener
10/09/2008CA2682727A1 Indoledione derivative
10/09/2008CA2682715A1 New imidazo[4,5-b]pyridine-7-carboxamides 704
10/09/2008CA2682708A1 Substituted pyrimidines
10/09/2008CA2682649A1 Imidazolidine carboxamide derivatives as p2x7 modulators
10/09/2008CA2682646A1 Pyrrolopyrimidine derivatives as jak3 inhibitors
10/09/2008CA2682639A1 Heterocyclic antiviral compounds
10/09/2008CA2682637A1 Non-nucleoside reverse transcriptase inhibitors
10/09/2008CA2682629A1 Pyrimidine hydrazide compounds as pgds inhibitors
10/09/2008CA2682622A1 Amidation process for the preparation of cathepsin k inhibitors
10/09/2008CA2682613A1 Oral care compositions containing a mixed tocopherol component
10/09/2008CA2682608A1 Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome
10/09/2008CA2682580A1 A method of modulating the activity of a nucleic acid molecule
10/09/2008CA2682572A1 New combination for use in the treatment of inflammatory disorders
10/09/2008CA2682567A1 Non-peptidic molecules for detecting and treating tumors
10/09/2008CA2682550A1 Peripheral opioid receptor antagonists and uses thereof
10/09/2008CA2682525A1 Production of a viable, storable worm egg suspension
10/09/2008CA2682493A1 Targeting agent for cancer cell or cancer-associated fibroblast
10/09/2008CA2682483A1 3-imidazolyl-indoles for the treatment of proliferative diseases
10/09/2008CA2682473A1 Novel pyrrolinone derivative and pharmaceutical composition comprising the same
10/09/2008CA2682441A1 Method for the treatment of fabry disease using pharmacological chaperones
10/09/2008CA2682384A1 Benzophenone hybrids as potential anticancer agents and a process for the preparation thereof
10/09/2008CA2682377A1 Heteroaryl derivatives
10/09/2008CA2682375A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous activity
10/09/2008CA2682374A1 Medicinal composition, food or drink having effect of enhancing sympathetic nervous activity
10/09/2008CA2682323A1 Methods and compositions for reduction of side effects of therapeutic treatments
10/09/2008CA2682231A1 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
10/09/2008CA2682230A1 Nucleoside phosphoramidate prodrugs
10/09/2008CA2682202A1 Benzylic glycoside derivatives and methods of use
10/09/2008CA2682185A1 Methods of separation and detection of bazedoxifene acetate in pharmaceutical compositions
10/09/2008CA2682183A1 Methods and compositions for selectin inhibition
10/09/2008CA2682161A1 Compositions and methods for inhibiting expression of a gene from the ebola
10/09/2008CA2682129A1 Crystal forms and uses thereof
10/09/2008CA2682125A1 Peripheral opioid receptor antagonists and uses thereof
10/09/2008CA2681979A1 Indole derivatives having cpla2 inhibiting activity and applications and production methods of the same
10/09/2008CA2681978A1 Heterocyclic spiro-compounds
10/09/2008CA2681803A1 Use of oligomers of lactic acid in the treatment of gynaecological infection
10/09/2008CA2681757A1 Methods and compositions for selectin inhibition
10/09/2008CA2681756A1 Inhibitors of bruton's tyrosine kinase
10/09/2008CA2681749A1 Combination therapy for the treatment-of lower urinary tract symptoms
10/09/2008CA2681733A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/09/2008CA2681712A1 Tamibarotene capsule preparation
10/09/2008CA2681708A1 Valsartan tablet formulations
10/09/2008CA2681586A1 1, 3-thiazol-2 (3h) -ylidene compounds as cannabinoid receptor ligands
10/09/2008CA2681582A1 Methods of treating bowel disorders
10/09/2008CA2681565A1 Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery
10/09/2008CA2681361A1 Methods for treating neovascular ocular diseases
10/09/2008CA2680636A1 Quinoline derivatives as crth2 receptor ligands
10/09/2008CA2680536A1 Oral disintegrating tablet
10/09/2008CA2680533A1 Mineralocorticoid receptor antagonists
10/09/2008CA2680407A1 Prophylactic and/or therapeutic agent for hyperlipidemia
10/09/2008CA2679728A1 Sub-type selective azabicycloalkane derivatives
10/08/2008EP1978362A2 Cross beta structure comprising amyloid binding proteins and methods for detection of the cross beta structure, for modulating cross beta structures fibril formation and for modulating cross beta structure-mediated toxicity
10/08/2008EP1978108A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
10/08/2008EP1978097A1 Regulation of transcription factor, NF-IL6/LAP
10/08/2008EP1978096A1 Novel oligonucleotide and nf-kappa b decoy comprising the same
1 ... 3052 3053 3054 3055 3056 3057 3058 3059 3060 3061 3062 3063 3064 3065 3066 3067 3068 3069 3070 3071 3072 ... 7860